Ischemic clinical trials at UCLA
1 research study open to eligible people
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
open to eligible people ages 30 years and up
An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.
Los Angeles, California
Our lead scientists for Ischemic research studies include David Liebeskind, MD.